DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-10.64%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.35B
AUM Growth
+$2.35B
(-1.2%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
126
New
15
Increased
30
Reduced
16
Closed
18
Top Buys
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$60.9M |
| 2 |
Editas Medicine
EDIT
|
$59M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$49.1M |
| 4 |
Viatris
VTRS
|
$36M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$34.1M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$84.3M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$53.5M |
| 3 |
Charles River Laboratories
CRL
|
$30.3M |
| 4 |
GHDX
Genomic Health, Inc.
GHDX
|
$28.5M |
| 5 |
Pacira BioSciences
PCRX
|
$28.5M |
Sector Composition
| 1 | Healthcare | 69.81% |
| 2 | Financials | 4.2% |
| 3 | Technology | 0.53% |
